Aquinnah Pharmaceuticals
Pre-clinicalA BOLD NEW APPROACH TO NEURODEGENERATIVE DISEASE - ALS and Alzheimer’s
Founded
2014
Focus
Small Molecules
About
A BOLD NEW APPROACH TO NEURODEGENERATIVE DISEASE - ALS and Alzheimer’s
Funding History
3Total raised: $18.2M
Grant$3.2MNIHJun 15, 2020
Series A$10MSanofi-Genzyme BioVenturesJun 15, 2018
Seed$5MALS Investment FundJun 15, 2015
Company Info
TypePrivate
Founded2014
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile